Internal Medicine

Predictive role of the Albumin-Bilirubin score in ICU patients with cirrhosis and sepsis: insights from a large retrospective cohort | BMC Gastroenterology

by

Decoding the Future of Liver Health in the ICU: The Rise of the ALBI Score As an editor deeply immersed in health science, I’ve been tracking the evolution of critical care medicine. One trend that’s particularly exciting is the increasing focus on *personalized risk assessment* in the ICU. The recent research highlighted in the provided … Read more

Remibrutinib for CSU Treatment

by

The Future of CSU Treatment: A Look at Oral Therapies and Patient Empowerment Chronic Spontaneous Urticaria (CSU), also known as chronic hives, can significantly impact a patient’s quality of life. Finding effective and convenient treatments is paramount. Recent advancements, particularly in oral therapies like remibrutinib, are reshaping the landscape, offering new hope and opportunities for … Read more

Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide

by

Navigating the Ethical Landscape of Future Healthcare: Trends and Challenges As medical advancements surge forward, especially in areas like immunotherapy and cellular therapies, the importance of ethical considerations and transparency in research becomes ever more critical. Recent data shows a significant increase in clinical trial participation, making it crucial to understand how competing interests and … Read more

Sepsis in patients with severe TBI: a retrospective CT scoring study | International Journal of Emergency Medicine

by

Navigating the Future of Brain Injury and Sepsis: Emerging Trends and Insights As a seasoned medical journalist, I’ve spent years immersed in the complex worlds of traumatic brain injury (TBI) and sepsis. These conditions, often intertwined, present significant challenges to healthcare professionals and, most importantly, to patients. Recent research, much of which you can find … Read more

Semaglutide Reduces Progression of PAD by 54% in Type 2 Diabetes

by

Semaglutide and PAD: Unveiling a Vascular Protective Revolution The medical world is abuzz with the latest findings on semaglutide, particularly its potential to revolutionize the treatment of peripheral artery disease (PAD) in individuals with type 2 diabetes. Recent data from the STRIDE trial, presented at the American Diabetes Association (ADA) Scientific Sessions, suggests the benefits … Read more

Higher Semaglutide Doses Yield Greater Weight Loss in Obesity

by

Semaglutide: A Glimpse into the Future of Obesity Management The medical landscape is constantly evolving, and the recent findings on semaglutide, particularly the higher dose (7.2 mg) of Wegovy, are reshaping how we approach obesity treatment. This injectable medication has shown remarkable results in clinical trials, offering new hope for individuals struggling to manage their … Read more

FDA Grants Orphan Drug Designation to DIAG723 for Treatment of HHT

by

New Hope on the Horizon: Promising Developments in Hereditary Hemorrhagic Telangiectasia (HHT) Treatment For those living with Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic disorder, managing its effects can be a constant challenge. Characterized by the formation of abnormal blood vessels, HHT often leads to recurrent bleeding and complications like anemia. But recent advancements offer … Read more

Modelled Weight Loss in an English Population Eligible for Bariatric Surgery: A Retrospective Open Cohort Study

by

Decoding the Future of Healthcare: Data, Obesity, and Bariatric Surgery The landscape of healthcare is rapidly evolving, fueled by advancements in data analysis, a growing understanding of obesity-related complications, and innovative treatment options like bariatric surgery. As experts, we’re seeing seismic shifts in how we approach patient care and preventative medicine. This article delves into … Read more

Alcohol-Associated Liver Disease Mortality Increased During, After COVID-19 Pandemic

by

Alcohol-Associated Liver Disease: Trends and Projections for the Future The landscape of liver health is constantly evolving, and recent studies have highlighted significant shifts in mortality rates related to Alcohol-Associated Liver Disease (ALD). Understanding these trends is crucial for public health professionals, healthcare providers, and individuals alike. This article delves into the latest findings, explores … Read more

Obicetrapib Reduces HbA1c, New-Onset Diabetes Risk in ASCVD, HeFH

by

Obicetrapib and the Future of Lipid Management: A New Horizon for Cardiovascular Health The world of cardiovascular medicine is constantly evolving, and recent research on obicetrapib offers a compelling glimpse into the future of treating heart disease. This emerging therapy, a highly specific cholesteryl ester transfer protein (CETP) inhibitor, is showing promise in reducing LDL-C … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]